Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies

NCT00521859 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancies

Interventions

DRUG: Cloretazine
DRUG: Fludarabine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]